Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Maher

Showing results (841-850 of 1,158) with videos related to

Pageof 116
Sort By:
Anatomical Sciences Education|December 18, 2014
Medical student perceptions of radiology use in anatomy teachingKevin P Murphy, Lee Crush, Eoin O'Malley, et al.
Journal of Neurogastroenterology and Motility|October 30, 2012
Computed tomography assessment of intestinal gas volumes in functional gastrointestinal disordersSebastian R Mc Williams, Patrick D Mc Laughlin, Owen J O'Connor, et al.
ERJ Open Research|June 24, 2025
Circulating prostasin is an independent marker of mortality risk in patients with idiopathic pulmonary fibrosisJamie L Todd, Courtney Page, Peitao Wu, et al.
Clinical Radiology|December 22, 2024
Computed tomography morphomics and antifibrotic therapy in idiopathic pulmonary fibrosisA T O'Mahony, M G Waldron, P J Henry, et al.
ERJ Open Research|June 1, 2023
Clinical trial simulations in pulmonary fibrosis: patient-focused insights and adaptationsSteve Jones, Maxine Flewett, Ron Flewett, et al.
BMJ Open Respiratory Research|June 11, 2019
Rationale, design and objectives of two phase III, randomised, placebo-controlled studies of GLPG1690, a novel autotaxin inhibitor, in idiopathic pulmonary fibrosis (ISABELA 1 and 2)Toby M Maher, Michael Kreuter, David J Lederer, et al.
The Lancet. Respiratory Medicine|April 7, 2016
Antacid therapy and disease outcomes in idiopathic pulmonary fibrosis: a pooled analysisMichael Kreuter, Wim Wuyts, Elisabetta Renzoni, et al.
Cancer Chemotherapy and Pharmacology|February 22, 2005
Role of glutathione and nucleotide excision repair in modulation of cisplatin activity with O6-benzylguanineMelissa L Fishel, Michael P Gamcsik, Shannon M Delaney, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|August 27, 2015
Ionizing radiation exposure as a result of diagnostic imaging in patients with lymphomaM P Crowley, S B O'Neill, B Kevane, et al.
ERJ Open Research|July 23, 2024
Circulating biomarkers and progression of idiopathic pulmonary fibrosis: data from the INMARK trialToby M Maher, R Gisli Jenkins, Vincent Cottin, et al.
Pageof 116

Showing results (841-850 of 1,158) with videos related to

Sort By:
Pageof 116
Anatomical Sciences Education|December 18, 2014
Medical student perceptions of radiology use in anatomy teachingKevin P Murphy, Lee Crush, Eoin O'Malley, et al.
Journal of Neurogastroenterology and Motility|October 30, 2012
Computed tomography assessment of intestinal gas volumes in functional gastrointestinal disordersSebastian R Mc Williams, Patrick D Mc Laughlin, Owen J O'Connor, et al.
ERJ Open Research|June 24, 2025
Circulating prostasin is an independent marker of mortality risk in patients with idiopathic pulmonary fibrosisJamie L Todd, Courtney Page, Peitao Wu, et al.
Clinical Radiology|December 22, 2024
Computed tomography morphomics and antifibrotic therapy in idiopathic pulmonary fibrosisA T O'Mahony, M G Waldron, P J Henry, et al.
ERJ Open Research|June 1, 2023
Clinical trial simulations in pulmonary fibrosis: patient-focused insights and adaptationsSteve Jones, Maxine Flewett, Ron Flewett, et al.
BMJ Open Respiratory Research|June 11, 2019
Rationale, design and objectives of two phase III, randomised, placebo-controlled studies of GLPG1690, a novel autotaxin inhibitor, in idiopathic pulmonary fibrosis (ISABELA 1 and 2)Toby M Maher, Michael Kreuter, David J Lederer, et al.
The Lancet. Respiratory Medicine|April 7, 2016
Antacid therapy and disease outcomes in idiopathic pulmonary fibrosis: a pooled analysisMichael Kreuter, Wim Wuyts, Elisabetta Renzoni, et al.
Cancer Chemotherapy and Pharmacology|February 22, 2005
Role of glutathione and nucleotide excision repair in modulation of cisplatin activity with O6-benzylguanineMelissa L Fishel, Michael P Gamcsik, Shannon M Delaney, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|August 27, 2015
Ionizing radiation exposure as a result of diagnostic imaging in patients with lymphomaM P Crowley, S B O'Neill, B Kevane, et al.
ERJ Open Research|July 23, 2024
Circulating biomarkers and progression of idiopathic pulmonary fibrosis: data from the INMARK trialToby M Maher, R Gisli Jenkins, Vincent Cottin, et al.
Pageof 116